Evidence map›Paper›PMID 32703158›Full record

ArticleBMC medical research methodology2020

COVID-19 prevalence estimation by random sampling in population - optimal sample pooling under varying assumptions about true prevalence.

Ola Brynildsrud

Abstract read
In one paragraph

Article in BMC medical research methodology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Detection ofInsects · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.Diagnostic microbiology and infectious disease · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Considerations for diagnostic COVID-19 tests.Nature reviews. Microbiology · 2021
    Review
  13. Sample pooling strategies for SARS-CoV-2 detection.Journal of virological methods · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ola BrynildsrudNorwegian Institute of Public Health, Oslo, Norway. olbb@fhi.no.ORCID 0000-0001-7566-4133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of confirmed COVID-19 cases divided by population size is used as a coarse measurement for the burden of disease in a population. However, this fraction depends heavily on the sampling intensity and the various test criteria used in different jurisdictions, and many sources indicate that a large fraction of cases tend to go undetected.

methodsEstimates of the true prevalence of COVID-19 in a population can be made by random sampling and pooling of RT-PCR tests. Here I use simulations to explore how experiment sample size and degrees of sample pooling impact precision of prevalence estimates and potential for minimizing the total number of tests required to get individual-level diagnostic results.

resultsSample pooling can greatly reduce the total number of tests required for prevalence estimation. In low-prevalence populations, it is theoretically possible to pool hundreds of samples with only marginal loss of precision. Even when the true prevalence is as high as 10% it can be appropriate to pool up to 15 samples. Sample pooling can be particularly beneficial when the test has imperfect specificity by providing more accurate estimates of the prevalence than an equal number of individual-level tests.

conclusionSample pooling should be considered in COVID-19 prevalence estimation efforts.

Indexed as

AlgorithmsBetacoronavirusCoronavirus InfectionsCOVID-19Diagnostic Tests, RoutineHumansPandemicsPneumonia, ViralPopulation SurveillancePrevalenceReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionSample SizeSARS-CoV-2Sensitivity and SpecificitySpecimen Handling

Identifiers

PMID32703158
PMCPMC7376319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.